Drugs / RTS,S/AS02D
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00289185 | Sep 2006 → Feb 2008 | malaria | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RTS,S/AS02(D) | “Safety, immunogenicity and efficacy of the RTS,S/AS02(D) vaccine candidate when integrated into a standard EPI schedule for infants have been reported over a nine-month...” PMID 23297680 ↗ Jan 2013 |
| Modality | Vaccine | “RTS,S/AS02D, a Candidate Malaria Vaccine” NCT00289185 ↗ |